Senior drivers who take sleeping pills at higher risk for crashes

drivers sleeping-pills risk rashesSenior drivers who take sleeping pills are at higher risk for vehicle crashes. The sleeping medication is known as zolpidem – commonly sold as Ambien.

The researchers of the study evaluated five years worth of driving records of 2,000 Alabama residents over the age of 70. The researchers compared residents who took sleeping pills to those who did not. The researchers found that women who took Ambien had a 61 percent higher probability of a crash over the course of five years compared to women who did not.


Senior study author Gerald McGwin said, “The risk was over twofold [higher] for all drivers over 80, [but] we haven’t demonstrated a cause and effect.”
“The literature on prescription medicines and driving is long,” added McGwin. A previous study found that sleeping pills users had a higher risk of car accidents compared to nonusers, and the results were not dependent on age.

In 2013, the FDA lowered the dosages of Ambien in order to minimize daytime fatigue. Producers of Ambien suggest that next-day fatigue is possible, and users should get the recommended seven to eight hours or sleep after taking Ambien in order to minimize this.

McGwin suggests that seniors with sleeping problems should discuss their issues with their doctor in order to uncover the best remedy for them – the safest one, too. This may include meditation or relaxation therapy.

Jonathan Adkins, executive director of the Governors Highway Safety Association, said, “We aren’t surprised that the study found a much higher crash rate for zolpidem users. We know that many medications have a detrimental effect on individuals’ ability to drive, and we suspect that drowsy driving is under-represented as a contributing factor in many crashes. The age-related finding is interesting and suggests that doctors and caregivers need to be especially careful when prescribing this medicine to older adults who are still driving.”


Author Bio

Mohan Garikiparithi got his degree in medicine from Osmania University (University of Health Sciences). He practiced clinical medicine for over a decade before he shifted his focus to the field of health communications. During his active practice he served as the head of the Dept. of Microbiology in a diagnostic centre in India. On a three-year communications program in Germany, Mohan developed a keen interest in German Medicine (Homoeopathy), and other alternative systems of medicine. He now advocates treating different medical conditions without the use of traditional drugs. An ardent squash player, Mohan believes in the importance of fitness and wellness.